axoCells Cortical Inhibitory Interneuron Progenitors (newborn male donor)
Specifications | |
---|---|
Product Category: | iPSC-Derived Cells |
Research Area: | Neuroscience |
Culture Properties: | Adherent |
Donor Age: | Newborn |
Donor Gender: | Male |
Reprogramming Method: | Episomal vector |
Product Description
axoCells Human iPSC-Derived Inhibitory Interneurons for maturation to inhibitory interneurons for neuroscience research.
- Assay ready in just 20 days
- Express the key markers including GAD65, Parvalbumin-B, GABA and Somatostatin
- Demonstrated functionality in advanced in vitro models including co-culture and tri-culture
These cells are have been used in co-culture methodologies to study Alzheimer's Disease, seizure and epilepsy.
Interneurons are the ‘brakes’ of the central nervous system. Connections between neurons in the brain are finely tuned and any increased electrical activity is dampened down by these cells. In the neocortex, the location for functions including sensory perceptions, emotion and cognition, interneurons represent between 20 and 30% of neurons.
axoCellsTM cortical inhibitory interneuron progenitors are derived from human iPSCs. In their progenitor state, the cells express the important Nkx-2.1 protein, indicative of mature parvalbumin and somatostatin interneuron development. After 20 days of culture, the cells mature to become interneurons. They will display key markers including parvalbumin, somatostatin, tyrosine hydroxylase, PAX-6, MAP2, beta-tubulin and GABA receptor and GAD enzyme. At day 30, the mature interneurons display functional calcium imaging responses to glutamic acid and glycine stimulation using the Axol NeurOne system.
Limited License Terms
Axol Bioscience's Limited License TermsGenetically Modified Organism (GVO)
See General Terms.
- Catalog Number
ax0667-GVO-AX - Supplier
Axol Bioscience - Size
- Shipping
Dry Ice